Evidence map›Paper›PMID 23949383›Full record

ArticleEpigenetics2013

Initial characterization of histone H3 serine 10 O-acetylation.

Laura-Mae P Britton, Alyshia Newhart, Natarajan V Bhanu, Rupa Sridharan, Michelle Gonzales-Cope, Kathrin Plath, Susan M Janicki, Benjamin A Garcia

Open access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Cataloging Posttranslational Modifications in Plant Histones.Advances in experimental medicine and biology · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Comprehensive Catalog of Currently Documented Histone Modifications.Cold Spring Harbor perspectives in biology · 2015
    Review
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Laura-Mae P BrittonDepartment of Molecular Biology; Princeton University; Princeton, NJ USA; Epigenetics Program; Department of Biochemistry and Biophysics; Perelman School of Medicine; University of Pennsylvania; Philadelphia, PA USA.
Alyshia NewhartMolecular and Cellular Oncogenesis Program; The Wistar Institute; Philadelphia, PA USA.
Natarajan V BhanuEpigenetics Program; Department of Biochemistry and Biophysics; Perelman School of Medicine; University of Pennsylvania; Philadelphia, PA USA.
Rupa SridharanUniversity of California Los Angeles; David Geffen School of Medicine; Department of Biological Chemistry; Jonsson Comprehensive Cancer Center; Molecular Biology Institute; Bioinformatics Interdepartmental Degree Program; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; Los Angeles, CA USA; Current affiliation: Wisconsin Institute for Discovery; Department of Cell and Regenerative Biology; University of Wisconsin; Madison, WI USA.
Michelle Gonzales-CopeDepartment of Molecular Biology; Princeton University; Princeton, NJ USA; Epigenetics Program; Department of Biochemistry and Biophysics; Perelman School of Medicine; University of Pennsylvania; Philadelphia, PA USA.
Kathrin PlathUniversity of California Los Angeles; David Geffen School of Medicine; Department of Biological Chemistry; Jonsson Comprehensive Cancer Center; Molecular Biology Institute; Bioinformatics Interdepartmental Degree Program; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; Los Angeles, CA USA.
Susan M JanickiMolecular and Cellular Oncogenesis Program; The Wistar Institute; Philadelphia, PA USA.
Benjamin A GarciaEpigenetics Program; Department of Biochemistry and Biophysics; Perelman School of Medicine; University of Pennsylvania; Philadelphia, PA USA.
Philadelphia University · USCalifornia University of Pennsylvania · USThe Wistar Institute · USUCLA Jonsson Comprehensive Cancer CenterUniversity of California, Los Angeles · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Roles of sumoylation and alternative polyadenylation in cellular reprogrammingP01GM099134 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HOCHEDLINGER, KONRAD · 2011 to 2021
$20.3M
Novel Methodology for Quantitative High-throughput Cancer EpigeneticsDP2OD007447 · OD · UNIVERSITY OF PENNSYLVANIA · PI GARCIA, BENJAMIN A · 2010 to 2010
$2.4M
Characterizing mechanisms of transcriptional activation using live cell imagingR01GM093000 · NIGMS · WISTAR INSTITUTE · PI JANICKI, SUSAN M · 2010 to 2014
$1.6M
NCI NIH HHS P30 CA010815NCI NIH HHS P30 CA10815NIGMS NIH HHS P01 GM099134NIGMS NIH HHS R01 GM093000NIGMS NIH HHS R01 GM 093000-02NIH HHS DP2 OD007447NIH HHS DP2OD007447
6 · The paper itself

Abstract

In eukaryotic organisms, histone posttranslational modifications (PTMs) are indispensable for their role in maintaining cellular physiology, often through their mediation of chromatin-related processes such as transcription. Targeted investigations of this ever expanding network of chemical moieties continue to reveal genetic, biochemical, and cellular nuances of this complex landscape. In this study, we present our findings on a novel class of histone PTMs: Serine, Threonine, and Tyrosine O-acetylation. We have combined highly sensitive nano-LC-MS/MS experiments and immunodetection assays to identify and validate these unique marks found only on histone H3. Mass spectrometry experiments have determined that several of these O-acetylation marks are conserved in many species, ranging from yeast to human. Additionally, our investigations reveal that histone H3 serine 10 acetylation (H3S10ac) is potentially linked to cell cycle progression and cellular pluripotency. Here, we provide a glimpse into the functional implications of this H3-specific histone mark, which may be of high value for further studies of chromatin.

Indexed as

AcetylationAnimalsCell CycleChromatinChromatography, LiquidDrosophilaEmbryonic Stem CellsFemaleHEK293 CellsHeLa CellsHistonesHumansMaleMicePluripotent Stem CellsProtein Processing, Post-TranslationalChromatinHistonesSerinechromatinepigeneticshistonemass spectrometrypost-translational modificationsproteomicsquantitativestem cells

Identifiers

PMID23949383
PMCPMC3891691
OpenAlexW2050888206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.